| Execution period | 5 years |
|---|
BSE filing, NSE: MUNJALSHOW. Summary written from the filing by ALFA Finder's alert engine.
Munjal Showa Ltd: key numbers
- Share price
- ₹121.51
- Market cap
- ₹486.0 Cr
- Revenue (annual)
- ₹1,315 Cr
- Net profit (annual)
- ₹21.87 Cr
- P/E (TTM)
- 19.6×Sector 30.5×
- Promoter holding
- 65.02%+0.00% QoQ
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Munjal Showa Ltd
All →Munjal Showa Other Announcement
Munjal Showa Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Munjal Showa Legal & Regulatory
Munjal Showa received a tax assessment notice from the Haryana Excise & Taxation Department totaling ₹3.27 Crore for assessment years 2008-09 to 2014-15.
- Value
- ₹3.27 Cr
Munjal Showa Annual General Meeting
Munjal Showa Limited held its 41st Annual General Meeting on August 24, 2026. Shareholders considered five business items including adoption of financial statements and dividend approval.
Munjal Showa Q1 FY27 Results: Net Profit ₹11.2 Cr, Up 34.9% YoY
Munjal Showa Ltd reported revenue from operations of ₹347.5 Cr (+21.5% YoY) and net profit of ₹11.2 Cr (+34.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹11.2 Cr · +34.9% YoY
Munjal Showa Annual Report
Munjal Showa has filed its Annual Report for the fiscal year 2025-26, which includes the Notice for the 41st Annual General Meeting of shareholders.
Munjal Showa Annual General Meeting
Munjal Showa Limited has scheduled its 41st Annual General Meeting for August 24, 2026, via video conferencing. The agenda includes dividend declaration and director appointments.
Other regulatory approval announcements
All →Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031
360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.